Randomised, phase 1, dose-finding study of MEDI4166, a PCSK9 antibody and GLP-1 analogue fusion molecule, in overweight or obese patients with type 2 diabetes mellitus
This is because obesity is a chronic and complex phenomenon, and its treatment is affected by multiple factors, not just medical ones
39 European Medicines Agency
Furthermore, AI and machine learning methodologies can be incorporated for real-world data analysis such as for surveying social media trends for better understanding of patient experiences and misconceptions about GLP-1 RAs, in identification of potential treatment barriers like insurance coverage limitations and concerns regarding side effects for developing targeted interventions and also in evaluation of treatment efficacy in real-world settings
If you're interested in retatrutide specifically, GLP3 Planner offers more comprehensive support including detailed titration guides, microdosing protocols, and educational content focused on this emerging triple-agonist medication